Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
Государственный научный центр социальной и судебной психиатрии им. В.П.Сербского
Список исп. литературыСкрыть список 1. Ястребов Д.В. Смена антидепрессивной терапии: причины и тактика. Лечебное дело. 2007; 3: 53–9. 2. Ястребов Д.В. Симптоматика, ассоциированная с прекращением приема антидепрессантов. Психиатр. и психофармакотер. 2008; 10: 51–6. 3. Ястребов Д.В., Алкеева-Костычева Е.А. Постепенная и одномоментная отмена бензодиазепиновых транквилизаторов, принимаемых в терапевтических дозах: каков результат? Рос. психиатр. журн. 2008; 1. 4. Ashton H., Young A. SSRIs, Drug Withdrawal and Abuse: Problem or Treatment? In: Selective Serotonin Reuptake Inhibitors (SSRIs): Past, Present and Future 1999; p. 65–80. 5. Barr LC, Goodman WK, Price LH. Physical symptoms associated with paroxetine discontinuation. Am J Psychiatry 1994; 151: 289. 6. Black K, Shea C, Dursun S, Kutcher S. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neuro Sci 2000; 25: 255–61. 7. Dave K, Harvey J, Aloyo V. The Time-Course for Up- and Down-Regulation of the Cortical 5-Hydroxytryptamine (5-HT)2A Receptor Density Predicts 5-HT2A Receptor-Mediated Behavior in the Rabbit. J Pharmacol and Experim Therapeutics 2007; 323: 327–35. 8. Dilsaver SC, Kronfol Z, Sackellares JC et al. Antidepressant withdrawal syndromes: Evidence supporting the cholinergic overdrive hypothesis. J Clin Psychopharmacol 1983; 3: 157–64. 9. Fava GA, Grandi S. Withdrawal syndrome after paroxetine and sertraline discontinuation. J Clin Psychopharmacol 1995; 15: 374–5. 10. Ferentz KS. A guide to switching antidepressant therapy. Pat Care 2007; 1. 11. Foreman J, Johansen T. Textbook of receptor pharmacology. CRC Press 2003; p. 189. 12. Green B. Persistent adverse neurological effects following SSRI discontinuation (PANES). Psychiatry On-Line 2002. 13. Haddad PM. Do antidepressants cause dependence? Epidemiologie e Psychiatria Socially 2005; 14: 58–62. 14. Hansen R, Gaynes B, Thieda P et al. Metaanalysis of Major Depressive Disorder Relapse and Recurrence With Second-Generation Antidepressants. Psychiatric Services 2008; 59: 1121–30. 15. Keuthen NJ, Cyr P, Riccaiardi JA et al. Medication withdrawal symptoms in obsessive-compulsive disorder patient treated with paroxetine. J Clin Psychopharmacol 1994; 14: 206–7. 16. Lathe R. Venlafaxine – Long Term Adverse Effects. Psychiatry On-Line 2002. 17. Lüllmann H, Mohr K et al. Pharmacology 2000; p. 75. 18. Mallya G, White K, Gunderson C. Is there a serotonergic withdrawal syndrome? Biol Psychiatry 1993; 33: 851–2. 19. Michelson D, Fava M, Amsterdam J et al. Interruption of selective serotonine reuptake inhibitor treatment. Brit J Psychiatry 2000; 176: 363–8. 20. Schatzberg AF, Haddad P, Kaplan E et al. Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. J Clin Psychiatry 1997; 58: 23–8. 21. Warner CH, Bobo W, Warner C et al. Antidepressant discontinuation syndrome. Am Fam Physician 2006; 74 (3): 449–56.